European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

AI responses may include mistakes. For legal advice, consult a professional. Learn more European Pharmacopoeia Tablet Standards | PDF - Scribd

Preparations for , which are covered by other monographs like Rectal preparations (1145) or Vaginal preparations (1164). Production Requirements

: Assessed via general chapter 2.9.7 to ensure tablets do not crumble or break during processing or transport.

Before a tablet ever reaches a patient, it must survive manufacturing, bottling, shipping, and handling. This is where the physical attributes described in 0478 come into play. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

The European Pharmacopoeia (Ph. Eur.) monograph for tablets, specifically "Tablets -0478-", provides a detailed framework for evaluating the quality of tablets. The monograph sets out requirements, test methods, and acceptance criteria for tablets, ensuring that medicinal products available to patients in Europe meet the required standards for quality, purity, and strength. By following this monograph, manufacturers, regulators, and control laboratories can ensure that tablets are produced and controlled to a high standard, ultimately contributing to patient safety and public health.

| Issue | Guidance | |-------|----------| | | Use a balance with appropriate precision (≥ 0.1 mg for < 50 mg tablets). | | Coated tablet friability | Not required by 0478, but may be requested by regulators if coating chips. | | Disintegration vs dissolution | Disintegration does not guarantee dissolution; dissolution is the definitive performance test. | | Uniformity of dosage units – mass variation eligibility | Check if active ingredient is ≥ 90% of core mass; otherwise, content uniformity is mandatory. | | Sugar-coated tablets disintegration | Time starts when tablet is placed in apparatus; coating must rupture within a few minutes. |

End.

: Since January 2018, revised standards mandate a suitable dissolution test for immediate-release forms unless otherwise justified.

The Ph. Eur. monograph for tablets (0478) plays a critical role in ensuring the quality of tablet products in Europe. By following this monograph, manufacturers can ensure that their products meet the required standards for quality, purity, and strength. The monograph also provides a common language and set of standards for regulatory authorities, manufacturers, and control laboratories to evaluate the quality of tablet products.

According to the Ph. Eur., tablets are solid dosage forms containing one or more APIs, compressed into a single unit. Tablets can be coated or uncoated, and may be designed to release the API(s) immediately or over a specified period. AI responses may include mistakes

: To ensure the tablet breaks apart in the digestive tract.

Monograph 0478 is a . This is a crucial distinction. It does not describe a specific drug (like paracetamol or ibuprofen); rather, it sets the universal rules for all tablets. Whether it is a simple painkiller, a complex modified-release heart medication, or an effervescent vitamin C tablet, 0478 applies.

: For tablets with break-marks, the efficacy of the mark is assessed by weighing subdivided parts. Not more than one out of 30 parts may fall outside 85% to 115% of the average mass. 4. Mandatory Pharmacopoeial Tests Production Requirements : Assessed via general chapter 2

: Formulated to be easily crushed by chewing before swallowing, avoiding the immediate need for a disintegration test. Key Technical and Analytical Requirements